Exact Sciences EXAS Stock
Exact Sciences Price Chart
Exact Sciences EXAS Financial and Trading Overview
| Exact Sciences stock price | 45.6 USD |
| Previous Close | 93.06 USD |
| Open | 92.57 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1200 |
| Day's Range | 92.07 - 94.05 USD |
| 52 Week Range | 29.27 - 94.05 USD |
| Volume | 1.03M USD |
| Avg. Volume | 1.8M USD |
| Market Cap | 16.85B USD |
| Beta (5Y Monthly) | 1.391197 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.59 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 88.07 USD |
EXAS Valuation Measures
| Enterprise Value | 18.66B USD |
| Trailing P/E | N/A |
| Forward P/E | -70.21804 |
| PEG Ratio (5 yr expected) | -0.46 |
| Price/Sales (ttm) | 7.660614 |
| Price/Book (mrq) | 5.49256 |
| Enterprise Value/Revenue | 8.483 |
| Enterprise Value/EBITDA | -61.482 |
Trading Information
Exact Sciences Stock Price History
| Beta (5Y Monthly) | 1.391197 |
| 52-Week Change | 152.26% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 94.05 USD |
| 52 Week Low | 29.27 USD |
| 50-Day Moving Average | 75.35 USD |
| 200-Day Moving Average | 56.51 USD |
EXAS Share Statistics
| Avg. Volume (3 month) | 1.8M USD |
| Avg. Daily Volume (10-Days) | 1.76M USD |
| Shares Outstanding | 180.48M |
| Float | 178.6M |
| Short Ratio | 4.37 |
| % Held by Insiders | 0.91% |
| % Held by Institutions | 88.22% |
| Shares Short | 9.38M |
| Short % of Float | 5.25% |
| Short % of Shares Outstanding | 5.19% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -23.48% |
| Operating Margin (ttm) | -22.87% |
| Gross Margin | 72.88% |
| EBITDA Margin | -13.79% |
Management Effectiveness
| Return on Assets (ttm) | -4.91% |
| Return on Equity (ttm) | -16.36% |
Income Statement
| Revenue (ttm) | 2.2B USD |
| Revenue Per Share (ttm) | 12.4 USD |
| Quarterly Revenue Growth (yoy) | 23.79% |
| Gross Profit (ttm) | 1.51B USD |
| EBITDA | -303552992 USD |
| Net Income Avi to Common (ttm) | -516720000 USD |
| Diluted EPS (ttm) | -2.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 698.65M USD |
| Total Cash Per Share (mrq) | 3.87 USD |
| Total Debt (mrq) | 2.57B USD |
| Total Debt/Equity (mrq) | 84.21 USD |
| Current Ratio (mrq) | 2.971 |
| Book Value Per Share (mrq) | 17.003 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -88020000 USD |
| Levered Free Cash Flow (ttm) | -242954496 USD |
Profile of Exact Sciences
| Country | United States |
| State | WI |
| City | Madison |
| Address | 5505 Endeavor Lane |
| ZIP | 53719 |
| Phone | 608 284 5700 |
| Website | https://www.exactsciences.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 6300 |
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Q&A For Exact Sciences Stock
What is a current EXAS stock price?
Exact Sciences EXAS stock price today per share is 45.6 USD.
How to purchase Exact Sciences stock?
You can buy EXAS shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Exact Sciences?
The stock symbol or ticker of Exact Sciences is EXAS.
Which industry does the Exact Sciences company belong to?
The Exact Sciences industry is Diagnostics & Research.
How many shares does Exact Sciences have in circulation?
The max supply of Exact Sciences shares is 185.76M.
What is Exact Sciences Price to Earnings Ratio (PE Ratio)?
Exact Sciences PE Ratio is now.
What was Exact Sciences earnings per share over the trailing 12 months (TTM)?
Exact Sciences EPS is -5.59 USD over the trailing 12 months.
Which sector does the Exact Sciences company belong to?
The Exact Sciences sector is Healthcare.
Exact Sciences EXAS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17166.04 USD — |
+2.74
|
6.86B USD — | 16744.97 USD — | 17174.35 USD — | — - | 6.86B USD — |
| NASDAQ Composite Total Return I XCMP | 21012.91 USD — |
+2.74
|
— — | 20497.47 USD — | 21023.08 USD — | — - | — — |
| Nasdaq US Smart Pharmaceuticals NQSSPH | 1330.18 USD — |
+1.71
|
— — | 1299.11 USD — | 1331 USD — | — - | — — |
| NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| NASDAQ HealthCare IXHC | 930.32 USD — |
+2.05
|
— — | 911.02 USD — | 930.5 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 102.7 USD — |
+1.99
|
— — | 100.62 USD — | 102.71 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2743.93 USD — |
+1.91
|
— — | 2691.56 USD — | 2748.42 USD — | — - | — — |
- {{ link.label }} {{link}}